Eugene Braunwald MD

The TIMI Study Group is an esteemed academic research organization affiliated with Brigham and Women's Hospital and Harvard Medical School, dedicated to advancing the understanding and treatment of cardiovascular disease since its establishment in 1984. With a diverse portfolio of over 80 trials conducted across 50 countries, the group focuses on innovative clinical trials that span phases I to IV, enrolling a vast range of subjects from those with risk factors to patients in acute care. Leveraging a comprehensive database of clinical findings, biomarkers, and genotypes, the TIMI Study Group plays a pivotal role in shaping cardiovascular medicine through large-scale international randomized controlled trials and sophisticated analyses. Celebrating its 40th anniversary in 2024, TIMI continues to lead transformative research that enhances patient care and improves outcomes for individuals suffering from cardiovascular conditions. Generated from the website

Brigham and Women's Hospital, located in Boston, MA, is a leading institution in patient care, medical education, and research, offering expertise across virtually every specialty of medicine and surgery. The hospital features a dedicated Department of Dermatology, providing comprehensive services including general dermatology, cutaneous oncology, and dermatologic surgery. With multiple locations, including specialized centers for phototherapy and skin health, Brigham and Women's Hospital is equipped to address a wide range of dermatologic needs. Their team of experts is committed to delivering high-quality care and support for both new and international patients seeking treatment. Generated from the website